Deborah Kilpatrick, PhD, CEO of Evidation Health, explains how the company is creating a way to validate the efficacy of digital tools in health care. Bonus Breaking Health Podcast Trivia: What famous Yankee game did Steve Krupa attend as a child?

Wellframe co-founder and CEO Jacob Sattelmair on how his company intends to win the race to create the most effective digital tools to engage patients and providers.

Canary Health is working with payers, providers, and Medtech suppliers like Medtronic to give patients – and their caregivers – the tools necessary to manage their chronic disease. Adam Kaufman, CEO and president, explains how his company is riding the “third wave” of health care.

Geoff Martha, executive vice president, Restorative Therapies Group, shares Medtronic’s view of Medtech. In this interview with Stacy Enxing Seng, venture partner/independent director, Martha lays out the Medtech giant’s strategy to grow a technology business while helping health care systems save money.

PureTech historically has focused on creating new biotech and medical device technologies. CEO and founder Daphne Zohar explains PureTech’s move into digital therapeutics, including companies that use sound and games to promote good health.

Psilos CEO Steve Krupa gets some well deserved time in the spotlight after hosting half a year’s worth of podcasts. In this interview we ask Steve why he agreed to host the podcast, how he become a VC, and how companies might pitch ideas to Psilos.

Quartet Health recently closed on a $40 million second round to build a support platform for behavorial health patients. The company partners with health systems to provide consistent online support for their patients. Investors include former Congressman Patrick Kennedy, GV (formerly Google Ventures), F-Prime Capital Partners, Polaris Partners and others.

Telemedicine player Pager is working with insurers and physicians to allow sick people to get treated in their homes. CEO and Co-founder Gaspard de Dreuzy explains how Pager is working to cut health care costs.

CEO and co-founder Owen Tripp goes back to share the origins of Grand Rounds’ mission, a meeting over coffee and pastries with co-founder Lawrence “Rusty” Hoffman, MD, to help patients find the appropriate doctor for their specific needs and diagnosis. Our Steve “Scoop” Krupa also digs up a bit of news.

Pear Therapeutics CEO Corey McCann, MD, PhD delves into the potential digital therapeutics have in helping people who abuse drugs and alcohol. The company’s product pipeline includes potential treatment for schizophrenia, combat-PTSD, generalized anxiety disorder, insomnia and traumatic brain injury.